Initial combination of linagliptin and metformin in patients with type 2 diabetes: efficacy and safety in a randomised, double-blind 1-year extension study

OBJECTIVE: To determine the efficacy and safety of linagliptin in initial combination with metformin in patients with type 2 diabetes. METHODS: This 1-year randomised, double-blind study was an extension of a 6-month randomised controlled trial, in which adults with type 2 diabetes received one of s...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Clin Pract
Main Authors: Haak, T, Meinicke, T, Jones, R, Weber, S, von Eynatten, M, Woerle, H-J
Formato: Artigo
Idioma:Inglês
Publicado: BlackWell Publishing Ltd 2013
Assuntos:
Endocrinology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4282285/
https://ncbi.nlm.nih.gov/pubmed/24118640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijcp.12308
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares